Clinical snapshot — for veterinary teams
- Active ingredient / class: lotilaner — isoxazoline flea/tick parasiticide (GABA-gated chloride channel inhibitor)
- Indication: monthly treatment and prevention of flea and tick infestations in dogs ≥8 weeks and ≥4.4 lb
- Administration: beef-flavored chewable, once monthly; must be given with a meal or within 30 minutes of feeding — bioavailability drops in the fasted state, so this directly affects efficacy
- Class safety note: isoxazoline — associated with neurologic events (tremors, ataxia, seizures), reported even in dogs without a prior seizure history
- Monitoring windows that matter: first-dose tolerance (neuro screen); monthly adherence; confirm it was given with food
- Counsel clients on: label’s most frequent reactions (weight loss, elevated BUN, increased urination, diarrhea); also vomiting, decreased appetite; the neuro signs above
- Cautions: dogs with seizures/neuro disorders; not established in breeding/pregnant/lactating dogs; contains pork liver, soy, barley, wheat, lactose (food-allergy note)
Plain answer for owners who landed here: Credelio is a monthly chewable that kills fleas and ticks. Most dogs tolerate it well; mild effects can include diarrhea, vomiting, or drinking/urinating more. Its ingredient (lotilaner) is in the isoxazoline class, which has rarely been linked to neurologic signs like tremors or seizures — even in dogs with no prior history — so tell your vet about any seizure history and watch your dog after the first dose. Always give it with food, and don’t skip a month.
What it’s used for — and why clients call about it
Credelio is one of the oral monthly isoxazoline flea-and-tick preventives. Two things drive the calls: the give-with-food rule (owners who dose on an empty stomach quietly undercut efficacy and then report “it’s not working”), and the isoxazoline class question — owners who’ve read about seizures and want reassurance, or who notice something after dosing. Both are follow-up moments where a quick, structured check protects the patient and the protocol.
The adverse-event and monitoring profile
Per the FDA-approved labeling, the most frequently reported reactions are weight loss, elevated BUN, increased urination, and diarrhea; vomiting and decreased appetite also occur. The class-level point belongs up front: lotilaner is an isoxazoline, and this class has been associated with neurologic adverse reactions — tremors, ataxia, and seizures — reported in dogs even without a prior seizure history. The label advises caution in dogs with seizures or neurologic disorders, and safe use hasn’t been established in breeding, pregnant, or lactating dogs. Because absorption is reduced when fasted, the drug must be given with a meal or within 30 minutes of feeding. (Sources: Credelio FDA-approved labeling via DailyMed; PetMD; Elanco product information; FDA isoxazoline fact sheet.)
The follow-up window that matters
Two windows. The first dose is the tolerance and neuro-screen window — most reactions are mild GI, but the isoxazoline class makes a deliberate neuro check worthwhile, especially in any dog with a seizure history. Then monthly adherence is the recurring task, and it’s tied to the food rule: a dose given on an empty stomach is a half-protected month even if the owner “didn’t miss” it.
What to ask clients at follow-up
A short check after the first dose and each month:
- Did you give it with food (a meal, or within 30 minutes of feeding)?
- Any vomiting, diarrhea, reduced appetite, or increased drinking/urination?
- Any wobbliness, tremors, twitching, or unusual behavior? (the isoxazoline neuro screen)
- Is next month’s dose scheduled?
The food question and the neuro screen are the two that genuinely change outcomes, and the monthly prompt keeps protection continuous.
Where compliance breaks down
Two ways: the dose given fasted (silent efficacy loss) and the skipped month (reopened flea/tick exposure). Neither announces itself — the owner believes they’re covered. And a subtle neurologic change can go unreported because the owner doesn’t connect it to the chew. Proactive follow-up catches all three.
Standardizing this follow-up without adding staff time
This is what Nidana Loop automates. After a Credelio dispense, Loop calls or texts the owner to confirm it was given with food, screen for GI and neurologic signs, and return it as a structured note to the clinic — flagging anything concerning for a vet. It then carries the monthly re-dose prompt, keeping protection continuous with no staff calls.
See Loop handle medication follow-up
Loop runs your first-dose tolerance and neuro screen, food-rule confirmation, and monthly reminders automatically — returning structured outcomes to the clinic. Book a 20-minute demo → · See how Loop works →
For pet owners
Do I have to give Credelio with food? Yes — give it with a meal or within 30 minutes of feeding, or it won’t be fully absorbed.
Is it safe? Most dogs tolerate it well. Its class (isoxazoline) has rarely been linked to neurologic signs like tremors or seizures, even in dogs without prior history — tell your vet about any seizure history.
How often is it given? Once a month, year-round for continuous protection.
What are the common side effects? Usually mild — diarrhea, vomiting, reduced appetite, or drinking/urinating more.
This article is general information, not veterinary advice. Owners should consult their veterinarian and follow the product’s FDA-approved label.
Sources: Credelio (lotilaner) FDA-approved labeling via DailyMed; Credelio via PetMD; FDA — isoxazoline flea/tick product fact sheet.